Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | Other: Observation of Ocrelizumab as Treatment in RRMS Patients | [1] Ocrelizumab Ocrelizumab | [1] D05218
D05218
| [1] MS4A1 MS4A1 💬 | [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 13 13 |
| 2 | Treatment I | - | - | - | - | [1] 46 46 |
| 3 | Treatment II | - | - | - | - | [1] 46 46 |
| 4 | Treatment III | - | - | - | - | [1] 46 46 |
| 5 | Treatment intervention | - | - | - | - | [1] 61 61 |
| 6 | Viral load driven treatment interruption | - | - | - | - | [1] 265 265 |